HomeCompareGPOVY vs PFE

GPOVY vs PFE: Dividend Comparison 2026

GPOVY yields 0.85% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GPOVY wins by $44.0K in total portfolio value
10 years
GPOVY
GPOVY
● Live price
0.85%
Share price
$14.14
Annual div
$0.12
5Y div CAGR
65.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$93.5K
Annual income
$37,082.19
Full GPOVY calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — GPOVY vs PFE

📍 GPOVY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGPOVYPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GPOVY + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GPOVY pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GPOVY
Annual income on $10K today (after 15% tax)
$72.14/yr
After 10yr DRIP, annual income (after tax)
$31,519.86/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, GPOVY beats the other by $9,199.96/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GPOVY + PFE for your $10,000?

GPOVY: 50%PFE: 50%
100% PFE50/50100% GPOVY
Portfolio after 10yr
$71.5K
Annual income
$31,670.46/yr
Blended yield
44.27%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

GPOVY
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
3.8
Piotroski
7/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GPOVY buys
0
PFE buys
0
No recent congressional trades found for GPOVY or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGPOVYPFE
Forward yield0.85%6.13%
Annual dividend / share$0.12$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR65.3%13.2%
Portfolio after 10y$93.5K$49.6K
Annual income after 10y$37,082.19$26,258.71
Total dividends collected$68.8K$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldHold

Year-by-year: GPOVY vs PFE ($10,000, DRIP)

YearGPOVY PortfolioGPOVY Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$10,840$140.28$9,153$693.39+$1.7KGPOVY
2$11,834$234.93$8,593$849.25+$3.2KGPOVY
3$13,059$396.20$8,336$1,066.78+$4.7KGPOVY
4$14,648$675.41$8,437$1,384.80+$6.2KGPOVY
5$16,844$1,170.42$9,013$1,875.40+$7.8KGPOVY
6$20,102$2,079.19$10,306$2,680.72+$9.8KGPOVY
7$25,343$3,833.38$12,820$4,101.38+$12.5KGPOVY
8$34,583$7,465.89$17,673$6,826.70+$16.9KGPOVY
9$52,742$15,738.92$27,543$12,591.86+$25.2KGPOVY
10$93,516$37,082.19$49,560$26,258.71+$44.0KGPOVY

GPOVY vs PFE: Complete Analysis 2026

GPOVYStock

Grupo Carso, S.A.B. de C.V., together with its subsidiaries, engages in the commercial, industrial, infrastructure and construction, and energy sectors. It operates through Commercial and Consumer, Industrial and Manufacturing, Infrastructure and Construction, and Energy divisions. The company's Commercial and Consumption division operates department stores and boutiques, gift shops, restaurants, coffee shops, electronics, and technology and games stores under the Sears, Sanborns, iShop, Mixup, Claro Shop, and Saks Fifth Avenue brands. The company's Industrial and Manufacturing division provides cables, such as energy, telecommunication, electronic, coaxial, and fiber optics for application in mining, automotive, and other; electric harnesses for automotive industry; precision steel tubing; power transformers; and alternate energy. It serves customers under the Condumex, Latincasa, Vinanel, Condulac, IEM, Precitubo, Sitcom, Microm, Sinergia, Equiter, and Logtec brands. The company's Infrastructure and Construction division constructs roads, tunnels, water treatment plants, and general infrastructure works; oil and geothermic well drilling and drilling services; and oil platforms and equipment for chemical and petroleum industries. It also constructs commercial centers, industrial plants, and office building and houses; and telecommunication facilities, gas pipelines, and aqueducts under the CICSA, Swecomex, Bronco Drilling, Cilsa, GSM, PC Construcciones, and Urvitec brands. The company's Energy division engages in the gas transportation services; and exploration and production of oil, gas, and other hydrocarbons, as well as explores geothermal energy under the Carso Energy, Carso Oil & Gas, and Carso Electric brands. It serves customers in Mexico; Central America, South America, and the Caribbean; the United States; Europe; and internationally. Grupo Carso, S.A.B. de C.V. is incorporated in 1980 and is headquartered in Mexico City, Mexico.

Full GPOVY Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this GPOVY vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GPOVY vs SCHDGPOVY vs JEPIGPOVY vs OGPOVY vs KOGPOVY vs MAINGPOVY vs JNJGPOVY vs MRKGPOVY vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.